Rani Therapeutics Holdings (RANI) Assets Average (2021 - 2026)

Rani Therapeutics Holdings has reported Assets Average for 6 years, with the latest figure at $56.4 million in Q2 2026.

• On a quarterly basis, Assets Average rose 174.78% year-over-year to $56.4 million in Q2 2026; TTM through Jun 2026 was $56.4 million, a 174.78% increase from a year earlier, with the FY2025 full-year figure at $47.6 million, up 0.75% from the prior year.
• Assets Average was $56.4 million for Q2 2026 at Rani Therapeutics Holdings, up from $55.2 million in the prior quarter.
• The five-year high for Assets Average was $119.8 million in Q1 2022, with the low at $13.5 million in Q3 2025.
• Average Assets Average over 5 years is $65.3 million, with a median of $56.0 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Assets Average tumbled 69.02% in 2025, then soared 174.78% in 2026.
• Over 5 years, Assets Average stood at $108.1 million in 2022, then tumbled by 40.64% to $64.2 million in 2023, then slumped by 37.54% to $40.1 million in 2024, then fell by 14.24% to $34.4 million in 2025, then jumped by 63.94% to $56.4 million in 2026.
• The last three Assets Average figures came in at $56.4 million (Q2 2026), $55.2 million (Q1 2026), and $34.4 million (Q4 2025), per Business Quant data.